搜索临床试验以:Selective androgen receptor modulator
总计38808个结果
-
University of Colorado, Denver主动,不招人
-
CHU de Quebec-Universite LavalGlaxoSmithKline完全的
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)完全的
-
GeneScience Pharmaceuticals Co., Ltd.Peking University People's Hospital完全的
-
University of ChicagoNational Cancer Institute (NCI)完全的
-
Dana-Farber Cancer InstituteNational Institute of Nursing Research (NINR)完全的
-
GlaxoSmithKlineParexel完全的
-
State University of New York at BuffaloAmerican Diabetes Association终止
-
Weill Medical College of Cornell University完全的
-
Repros Therapeutics Inc.完全的
-
Repros Therapeutics Inc.完全的
-
University of WashingtonNational Institute on Aging (NIA); Solvay Pharmaceuticals完全的
-
Zhongshan Bo Ai Hospital完全的研究者选取534例PCOS患者作为病例组,580例排卵周期正常的不孕女性作为对照组; | 同时,研究者继续收集病例至2012年10月,共收集PCOS患者579例; | 病例组中的 534 名患者和对照组中的 580 名女性未接受任何措施,而 579 名患者接受了药物治疗; | 研究者监测了本次调查所有受试者的血液基本指标,同时监测了579例患者治疗后的各项指标。中国
-
Chinese University of Hong KongUniversity of Palermo; University of Malaya; Singapore General Hospital; University Hospital, Bordeaux 和其他合作者尚未招聘门静脉高压症 | 晚期慢性肝病 | 肝脏失代偿
-
Roswell Park Cancer Institute尚未招聘解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IV 期乳腺癌 AJCC v8 | 转移性三阴性乳腺癌 | 局部晚期不可切除的三阴性乳腺癌美国
-
Massachusetts General HospitalPatient-Centered Outcomes Research Institute尚未招聘
-
MedSIRStemline Therapeutics, Inc.尚未招聘晚期乳腺癌 | ER阳性乳腺癌 | HER2 阴性乳腺癌 | ESR1基因突变
-
Andrea DeCensiHerbert Irving Comprehensive Cancer Center; Breast Cancer Research Foundation; Istituto Europeo... 和其他合作者尚未招聘
-
International Research Training Group 2804German Research Foundation; Uppsala University; University Hospital Tuebingen尚未招聘
-
University of Chicago尚未招聘
-
University College, LondonNovartis; Cancer Research UK; Janssen Pharmaceutica NV尚未招聘
-
Region Örebro CountyMid-Sweden Regional Cancer Centre; Akademiska University Hospital, Uppsala, Sweden尚未招聘
-
National Cancer Institute (NCI)尚未招聘
-
National Cancer Institute (NCI)尚未招聘